Sponsors (17)
The bill expands beneficiary choice and shore up retail pharmacy payments and oversight to protect access to maintenance medications, but does so at the likely expense of higher TRICARE pharmacy spending, potential regional cost disparities, and added administrative burdens.
TRICARE beneficiaries with chronic conditions can obtain non‑generic maintenance medications through multiple channels starting Oct 1, 2026, improving convenience and continuity of care.
Retail pharmacies (and the local retail network) will receive higher and more predictable reimbursements—at or above actual wholesale acquisition cost or NADAC plus a State Medicaid dispensing fee—and cannot be charged point‑of‑sale, retroactive, or hidden fees, reducing financial losses and helping preserve local pharmacy access.
Annual GAO audits, required data sharing, and a required 90‑day DoD implementation plan increase transparency, congressional oversight, and accelerate deployment of beneficiary protections.
Higher reimbursement floors and mandated dispensing fees are likely to increase TRICARE pharmacy spending, which could raise costs for taxpayers or require offsetting budget cuts elsewhere.
Contractors blocked from charging point‑of‑sale or retroactive fees may seek to recoup revenue by requesting higher administrative payments or narrowing services/formulary arrangements, potentially affecting program costs and beneficiary access indirectly.
If State Medicaid dispensing fees vary widely, TRICARE reimbursements could be much higher in some states than others, creating uneven costs and potential regional disparities in pharmacy participation and access (risk to rural communities in particular).
Based on analysis of 2 sections of legislative text.
Allows eligible TRICARE beneficiaries to elect non‑generic maintenance meds and requires retail pharmacies be reimbursed at WAC or NADAC plus the state Medicaid dispensing fee, bans contractor fees, and mandates GAO audits.
Allows eligible TRICARE beneficiaries, beginning October 1, 2026, to choose how they receive non‑generic maintenance prescriptions and requires TRICARE retail pharmacies to be reimbursed at least at either their actual wholesale acquisition cost or NADAC (if listed) plus a professional dispensing fee equal to the State Medicaid dispensing fee where the pharmacy is located. The bill also bans contractors from charging fees to TRICARE retail pharmacies, mandates annual GAO audits of contractor reimbursement reporting and network adequacy, and requires contractors to provide information needed for those audits. The Secretary of Defense must submit an implementation plan to the congressional defense committees within 90 days of enactment. The changes expand beneficiary choice and create statutory minimum reimbursement and transparency requirements for retail pharmacies participating in TRICARE rather than merely making technical edits to existing law.
Introduced December 3, 2025 by Jennifer Kiggans · Last progress December 3, 2025